Krsnaa Diagnostics Limited (NSE:KRSNAA)
India · Delayed Price · Currency is INR 500.50
+6.90 (1.40%)
Nov 11, 2026, 2:45 PM IST
Krsnaa Diagnostics Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 8,856 | 7,728 | 7,172 | 6,196 | 4,871 | 4,555 |
Revenue Growth | 16.59% | 7.75% | 15.74% | 27.20% | 6.95% | 14.88% |
Gross Profit Gross Profit Growth | 6,901 | 5,878 | 5,445 | 4,683 | 3,972 | 3,799 |
Operating Income Operating Income Growth | 1,335 | 1,215 | 1,018 | 697.54 | 692.39 | 903.37 |
Net Income Net Income Growth | 981.04 | 1,014 | 776.08 | 568.37 | 621.11 | 683.88 |
Earnings Per Share EPS Growth | 29.96 | 30.88 | 23.56 | 17.31 | 19.29 | 22.88 |
EPS Growth | 16.67% | 31.07% | 36.11% | -10.26% | -15.69% | 86.72% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 1,916 | 3,607 | 684.36 | 1,752 | 1,088 | 2,419 |
Total Debt Total Debt Growth | 5,964 | 5,343 | 2,035 | 1,598 | 324.81 | 409.92 |
Net Cash (Debt) Net Cash Growth | -4,048 | -1,736 | -1,351 | 153.97 | 763.15 | 2,009 |
Net Cash Growth | - | - | - | -79.82% | -62.01% | - |
Net Cash Per Share Net Cash Per Share Growth | -123.65 | -52.86 | -41.00 | 4.69 | 23.70 | 67.22 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 1,700 | 1,431 | 873.27 | 243.45 | 763.01 | 1,284 |
Capital Expenditures CapEx Growth | -3,660 | -2,193 | -1,266 | -1,939 | -1,414 | -1,322 |
Free Cash Flow Free Cash Flow Growth | -1,959 | -761.61 | -393 | -1,695 | -650.59 | -37.95 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 77.93% | 76.06% | 75.92% | 75.58% | 81.53% | 83.41% |
Operating Margin | 15.08% | 15.72% | 14.20% | 11.26% | 14.21% | 19.84% |
Pretax Margin | 14.29% | 16.87% | 14.32% | 11.30% | 16.46% | 18.99% |
Profit Margin | 11.08% | 13.13% | 10.82% | 9.17% | 12.75% | 15.02% |
FCF Margin | -22.13% | -9.86% | -5.48% | -27.36% | -13.36% | -0.83% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 2.000 | 2.000 | 2.750 | 2.500 | 2.750 | 2.500 |
Dividend Per Share Growth | -27.27% | -27.27% | 10.00% | -9.09% | 10.00% | - |
Dividend Yield | 0.40% | 0.38% | 0.35% | 0.41% | 0.60% | 0.51% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 16.70 | 16.64 | 32.78 | 34.92 | 23.26 | 22.44 |
Forward PE | 14.03 | 14.28 | 23.03 | 20.84 | 16.50 | 18.57 |
PS Ratio | 1.81 | 2.18 | 3.55 | 3.20 | 2.97 | 3.37 |